Diabetes duration |
Stage |
Clinical features |
Prognosis |
Since disease onset |
1: Increased eGFR, renal hypertrophy |
eGFR increased to 160 mL/min/1.73 m2, kidney enlargement (20%) and increase in renal plasma flow (10%-15%), no albuminuria or hypertension |
Potentially reversible |
2-5 years |
2: Onset of histologic changes, altered structure and function of basement membrane |
Thickening and altered electrical charge of basement membrane, mesangial proliferation, normal eGFR, no albuminuria, no clinical symptoms |
May be partially reversible |
5-10 (15) years |
3: Early clinical nephropathy |
Albuminuria 30-300 mg/24 h, eGFR reduced from 160 to 130 mL/min/1.73 m2, ± HTN |
Lesion progression may be stopped, sometimes reversible |
10 (15)-25 years |
4: Overt nephropathy |
Persistent and irreversible proteinuria, eGFR <60 mL/min/1.73 m2 and sustained HTN, edema, dyslipidemia |
Lesion progression may be slowed and sometimes stopped |
>15 years |
5: Renal failure |
End-stage kidney disease with eGFR <15 mL/min/1.73 m2, HTN |
Irreversible progression to end-stage renal failure |
Based on Diabetes. 1983;32 Suppl 2:64-78. | |||
eGFR, estimated glomerular filtration rate; HTN, hypertension. |